Time & location: 12:00PM, Virtual
Hosted By Cambridge Healthtech Institute
Agenda:
Hosted by Cambridge Healthtech Institute, this webinar describes how blood biomarkers can be used to detect CNS disorders. Dr. Henrik Zetterberg discusses the biology of NFL, including selected case studies in neurodegeneration using our Simoa Homebrew technology. You also hear from Dr. Jens Kuhle as he discusses his findings on serum NFL in Multiple Sclerosis using Simoa Technology.
Speakers:
Dr. Henrik Zetterberg
Professor of Neurochemistry and Head of Department at University of Gothenburg, Professor of Neurochemistry at University College London and Senior Consultant in Clinical Chemistry at Sahlgrenska University Hospital
PD Jens Kuhle, MD, PhD
Vice Head Outpatient Clinic and MS Centre, Neurology
University Hospital Basel
Miss the webinar? Click to listen to the full presentation here.
Related Posts
Accelerate Building Custom Spatial Proteomic Panels for New Biological Insights
Ultrasensitive Neuroimmune Biomarker Measurement for Translational Research and Therapeutic Development
Underdiagnosis of Alzheimer’s disease pathology in patients with cardiovascular disease
Decoding Neurodegeneration: High-plex Spatial Proteomics Reveal Distinct Cell Phenotypes and Pathological Signatures in Parkinson’s and Alzheimer’s Disease
In this webinar, Dr. Birgitt Schuele, Associate Professor (Research) of Pathology at Stanford University, showcases how ultrahigh-plex spatial proteomics is being used to uncover distinct cell phenotypes and pathological signatures…
Understanding the Brain: Advancing Neurodegeneration Research with Ultrahigh-Plex Spatial Proteomics
In this webinar, learn how ultrahigh-plex spatial phenotyping has been applied to neurodegenerative disease research.
p-Tau 205 and p-Tau 212: Emerging Biomarkers for Alzheimer’s Disease Research
Spatial Awareness: AI-powered Profiling of Trillions of Immune Cell Distribution Data Points Reveals Key Predictors of Cancer Recurrence Risk
This webinar highlights a groundbreaking study recently published as a Nature cover story (April 2025). Dr. Joe Yeong will describe how a pre-designed analytical framework—driven by well-defined clinical and scientific…
Multimodal Single-Cell Spatial Transcriptomics and Proteomics to Uncover the Biological Processes Driving Immunotherapy Response and Resistance in Renal Cancer
In this webinar, Dr. Anne-Laure Cattin from the Cancer Dynamics Laboratory at The Francis Crick Institute in London, will share her research on kidney cancer, focusing on the integration of…